国产精品国产一级毛片_亚洲AⅤ永久无码精品毛片69_亚洲最新a级片在线观看_91丨国产丨白丝_亚洲一级片免费在线观看_三级片免费看国产_欧美精品一级视频_北条麻妃久久99精品_无码中文字幕伊人_精品区免费视频亚洲

Poly Pharm adheres to the advanced manufacturing positioning of "differentiation + vertical integration of API and finished product  + internationalization", strictly requiring drug quality comply with international GMP  standards. It has established a complete quality system, standardized quality management and control systems, procedures and standards. The company has accumulated rich technical reserves and experience in drug formulation technology research and formulation global registration. In recent years, the company has continuously increased its R&D investment in the combination of"generic and innovative" research, targeting at those products with high technical difficulty and differentiation, and it has established an innovative drug research institute, a biotechnology research institute, a generic drug research institute, and a API research institute, with over 550 R&D personnel, accounting for one-third of the company's total employees.